Apex Capital Management’s DexCom DXCM Stock Holding History

Apex Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$42M	Buy	2,476,556 +18,864	+0.8%	+$315K	0.93%	43
2015 Q4	$50.3M	Buy	2,457,692 +10,584	+0.4%	+$220K	1.12%	32
2015 Q3	$52.5M	Sell	2,447,108 -402,540	-14%	-$8.98M	1.19%	29
2015 Q2	$57M	Buy	2,849,648 +142,044	+5%	+$2.49M	1.22%	30
2015 Q1	$42.2M	Buy	2,707,604 +59,244	+2%	+$895K	0.99%	40
2014 Q4	$36.4M	Buy	2,648,360 +227,576	+9%	+$2.79M	0.97%	42
2014 Q3	$24.2M	Buy	2,420,784 +2,154,304	+808%	+$22M	0.73%	56
2014 Q2	$2.64M	Buy	266,480 +37,536	+16%	+$333K	0.08%	166
2014 Q1	$2.37M	Sell	228,944 -86,444	-27%	-$894K	0.08%	169
2013 Q4	$2.79M	Buy	315,388 +3,204	+1%	+$25.4K	0.1%	146
2013 Q3	$2.2M	Buy	+312,184	New	+$1.98M	0.1%	157

Other funds holding DXCM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Apex Capital Management's DXCM Position: Q1 2016 in Review

Apex Capital Management increased its DexCom (DXCM) stake by 0.77% in Q1 2016, buying an estimated $315K and bringing the position to 2,476,556 shares worth $42M. The position accounts for 0.93% of the portfolio, ranked #43.

Apex Capital Management first reported a position in DXCM in Q3 2013 and has held it in 11 quarters since. The position peaked at $57M in Q2 2015. 264 funds tracked by Wall St. Rank hold DXCM as of Q1 2016.

Apex Capital Management held 2,476,556 shares of DexCom worth $42M as of Q1 2016.
Apex Capital Management bought 18,864 DexCom shares in Q1 2016, an estimated $315K.
DexCom made up 0.93% of Apex Capital Management's portfolio in Q1 2016, its #43 holding.
Apex Capital Management first reported a position in DexCom in Q3 2013 and has held it in 11 quarters since.
Apex Capital Management's DexCom position peaked at $57M in Q2 2015.
264 funds tracked by Wall St. Rank held DexCom as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.